{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,17]],"date-time":"2025-10-17T13:46:40Z","timestamp":1760708800863},"reference-count":31,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2015,3,24]],"date-time":"2015-03-24T00:00:00Z","timestamp":1427155200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Thromb Thrombolysis"],"published-print":{"date-parts":[[2015,7]]},"DOI":"10.1007\/s11239-015-1207-5","type":"journal-article","created":{"date-parts":[[2015,3,23]],"date-time":"2015-03-23T15:29:43Z","timestamp":1427124583000},"page":"88-96","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Impact of cytochrome P450 2C19*2 polymorphism on intra-stent thrombus assessed by follow-up optical coherence tomography in Chinese patients receiving clopidogrel"],"prefix":"10.1007","volume":"40","author":[{"given":"Shan","family":"Li","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yang","family":"Shi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Haijun","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wei","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jianfeng","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2015,3,24]]},"reference":[{"key":"1207_CR1","doi-asserted-by":"crossref","first-page":"1821","DOI":"10.1001\/jama.2010.1543","volume":"304","author":"JL Mega","year":"2010","unstructured":"Mega JL, Simon T, Collet JP, Anderson JL, Antman EM, Bliden K et al (2010) Reduced-function CYP2C19 genotype and risk of adverse clinical outcomes among patients treated with clopidogrel predominantly for PCI: a meta-analysis. JAMA 304:1821\u20131830","journal-title":"JAMA"},{"key":"1207_CR2","doi-asserted-by":"crossref","first-page":"2704","DOI":"10.1001\/jama.2011.1880","volume":"306","author":"MV Holmes","year":"2011","unstructured":"Holmes MV, Perel P, Shah T, Hingorani AD, Casas JP (2011) CYP2C19 genotype, clopidogrel metabolism, platelet function, and cardiovascular events: a systematic review and meta-analysis. JAMA 306:2704\u20132714","journal-title":"JAMA"},{"key":"1207_CR3","doi-asserted-by":"crossref","first-page":"1765","DOI":"10.1001\/jama.2011.1529","volume":"306","author":"G Cayla","year":"2011","unstructured":"Cayla G, Hulot JS, O\u2019Connor SA, Pathak A, Scott SA, Gruel Y et al (2011) Clinical, angiographic, and genetic factors associated with early coronary stent thrombosis. JAMA 306:1765\u20131774","journal-title":"JAMA"},{"key":"1207_CR4","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1001\/jama.2009.1232","volume":"302","author":"AR Schuldiner","year":"2009","unstructured":"Schuldiner AR, O\u2019Connell JR, Bliden KP, Gandhi A, Ryan K, Horenstein RB et al (2009) Association of cytochrome P450 2C19 genotype with the antiplatelet effect and clinical efficacy of clopidogrel therapy. JAMA 302:849\u2013858","journal-title":"JAMA"},{"key":"1207_CR5","doi-asserted-by":"crossref","first-page":"916","DOI":"10.1093\/eurheartj\/ehp041","volume":"30","author":"D Sibbing","year":"2009","unstructured":"Sibbing D, Stegherr J, Latz W, Koch W, Mehilli J, Dorrler K et al (2009) Cytochrome P450 2C19 loss-of-function polymorphism and stent thrombosis following percutaneous coronary intervention. Eur Heart J 30:916\u2013922","journal-title":"Eur Heart J"},{"key":"1207_CR6","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1056\/NEJMoa0809171","volume":"360","author":"JL Mega","year":"2009","unstructured":"Mega JL, Close SL, Wiviott SD, Wiviott SD, Shen L, Hockett RD et al (2009) Cytochrome P450 polymorphism and response to clopidogrel. N Engl J Med 360:354\u2013362","journal-title":"N Engl J Med"},{"key":"1207_CR7","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.amjcard.2009.02.045","volume":"104","author":"JM Lee","year":"2009","unstructured":"Lee JM, Park S, Shin DJ, Choi D, Shim CY, Ko YG et al (2009) Relation of genetic polymorphisms in the cytochrome P450 gene with clopidogrel resistance after drug eluting stent implantation in Koreans. Am J Cardiol 104:46\u201351","journal-title":"Am J Cardiol"},{"key":"1207_CR8","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.thromres.2010.10.021","volume":"127","author":"SJ Hwang","year":"2011","unstructured":"Hwang SJ, Jeong YH, Kim IS, Koh JS, Kang MK, Park Y et al (2011) The cytochrome 2C19*2 and *3 alleles attenuate response to clopidogrel similarly in East Asian patients undergoing elective percutaneous coronary intervention. Thromb Res 127:23\u201328","journal-title":"Thromb Res"},{"key":"1207_CR9","doi-asserted-by":"crossref","first-page":"992","DOI":"10.1093\/eurheartj\/ehn046","volume":"29","author":"MJ Price","year":"2008","unstructured":"Price MJ, Endemann S, Gollapudi RR, Valencia R, Stinis CT, Levisay JP et al (2008) Prognostic significance of post-clopidogrel platelet reactivity assessed by a point-of-care assay on thrombotic events after drug-eluting stent implantation. Eur Heart J 29:992\u20131000","journal-title":"Eur Heart J"},{"key":"1207_CR10","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1161\/CIRCULATIONAHA.108.812636","volume":"119","author":"R Marcucci","year":"2009","unstructured":"Marcucci R, Gori AM, Paniccia R, Giusti B, Valente S, Giglioli C et al (2009) Cardiovascular death and nonfatal myocardial infarction in acute coronary syndrome patients receiving coronary stenting are predicted by residual platelet reactivity to ADP detected by a point-of-care assay: a 12-month follow-up. Circulation 119:237\u2013242","journal-title":"Circulation"},{"key":"1207_CR11","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1016\/j.jacc.2010.04.047","volume":"56","author":"L Bonello","year":"2010","unstructured":"Bonello L, Tantry US, Marcucci R, Blindt R, Angiolillo DJ, Becker R et al (2010) Consensus and future directions on the definition of high on-treatment platelet reactivity to adenosine diphosphate. J Am Coll Cardiol 56:919\u2013933","journal-title":"J Am Coll Cardiol"},{"key":"1207_CR12","first-page":"127","volume":"3","author":"J Tanigawa","year":"2007","unstructured":"Tanigawa J, Barlis P, Di Mario C (2007) Intravascular optical coherence tomography: optimisation of image acquisition and quantitative assessment of stent strut apposition. EuroIntervention 3:127\u2013136","journal-title":"EuroIntervention"},{"key":"1207_CR13","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1093\/eurheartj\/ehl413","volume":"28","author":"D Matsumoto","year":"2007","unstructured":"Matsumoto D, Shite J, Shinke T, Otake H, Tanino Y, Ogasawara D et al (2007) Neointimal coverage of sirolimus-eluting stents at 6-month follow-up: evaluated by optical coherence tomography. Eur Heart J 28:961\u2013967","journal-title":"Eur Heart J"},{"key":"1207_CR14","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1016\/j.jcin.2009.03.003","volume":"2","author":"H Otake","year":"2009","unstructured":"Otake H, Shite J, Ako J, Shinke T, Tanino Y, Ogasawara D et al (2009) Local determinants of thrombus formation following sirolimus-eluting stent implantation assessed by optical coherence tomography. JACC Cardiovasc. Interv 2:459\u2013466","journal-title":"JACC Cardiovasc. Interv"},{"key":"1207_CR15","doi-asserted-by":"crossref","first-page":"2344","DOI":"10.1161\/CIRCULATIONAHA.106.685313","volume":"115","author":"DE Cutlip","year":"2007","unstructured":"Cutlip DE, Windecker S, Mehran R, Boam A, Cohen DJ, van Es GA et al (2007) Clinical end points in coronary stent trials: a case for standardized definitions. Circulation 115:2344\u20132351","journal-title":"Circulation"},{"key":"1207_CR16","doi-asserted-by":"crossref","first-page":"2108","DOI":"10.1016\/j.jacc.2005.11.092","volume":"47","author":"J Kotani","year":"2006","unstructured":"Kotani J, Awata M, Nanto S, Uematsu M, Oshima F, Minamiguchi H et al (2006) Incomplete neointimal coverage of sirolimus-eluting stents: angioscopic findings. J Am Coll Cardiol 47:2108\u20132111","journal-title":"J Am Coll Cardiol"},{"key":"1207_CR17","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1002\/ccd.22267","volume":"75","author":"H Nagai","year":"2010","unstructured":"Nagai H, Ishibashi-Ueda H, Fujii K (2010) Histology of highly echolucent regions in optical coherence tomography images from two patients with sirolimus-eluting stent restenosis. Catheter Cardiovasc Interv 75:961\u2013963","journal-title":"Catheter Cardiovasc Interv"},{"key":"1207_CR18","doi-asserted-by":"crossref","first-page":"380","DOI":"10.4244\/EIJV6I3A63","volume":"6","author":"Y Oikawa","year":"2010","unstructured":"Oikawa Y, Yajima J, Costa MA, Matsuno S, Akabane M, Funada R et al (2010) Intravascular ultrasound, angioscopic and histopathological characterisation of heterogeneous patterns of restenosis after sirolimus-eluting stent implantation: insights into potential \u201cthromborestenosis\u201d phenomenon. EuroIntervention 6:380\u2013387","journal-title":"EuroIntervention"},{"key":"1207_CR19","doi-asserted-by":"crossref","first-page":"2435","DOI":"10.1161\/CIRCULATIONAHA.107.693739","volume":"115","author":"AV Finn","year":"2007","unstructured":"Finn AV, Joner M, Nakazawa G, Kolodgie F, Newell J, John MC et al (2007) Pathological correlates of late drug-eluting stent thrombosis: strut coverage as a marker of endothelialization. Circulation 115:2435\u20132441","journal-title":"Circulation"},{"key":"1207_CR20","first-page":"2221","volume":"306","author":"JL Mega","year":"2011","unstructured":"Mega JL, Hochholzer W, Frelinger AL 3rd, Kluk MJ, Angiolillo DJ, Kereiakes DJ et al (2011) Dosing clopidogrel based on CYP2C19 genotype and the effect on platelet reactivity in patients with stable cardiovascular disease. JAMA 306:2221\u20132228","journal-title":"JAMA"},{"key":"1207_CR21","doi-asserted-by":"crossref","first-page":"1220","DOI":"10.1016\/j.jcin.2010.07.017","volume":"3","author":"A Caixeta","year":"2010","unstructured":"Caixeta A, Lansky AJ, Serruys PW, Hermiller JB, Ruygrok P, Onuma Y et al (2010) Clinical follow-up 3\u00a0years after everolimus- and paclitaxel-eluting stents: a pooled analysis from the SPIRIT II and SPIRIT III randomized trials. J. Am. Coll. Cardiol. Interv. 3:1220\u20131228","journal-title":"J. Am. Coll. Cardiol. Interv."},{"key":"1207_CR22","doi-asserted-by":"crossref","first-page":"1379","DOI":"10.1136\/hrt.2010.204339","volume":"97","author":"T Inoue","year":"2011","unstructured":"Inoue T, Shite J, Yoon J, Shinke T, Otake H, Sawada T et al (2011) Optical coherence evaluation of everolimus-eluting stents 8\u00a0months after implantation. Heart 97:1379\u20131384","journal-title":"Heart"},{"key":"1207_CR23","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1016\/j.jacc.2013.03.037","volume":"62","author":"PA Gurbel","year":"2013","unstructured":"Gurbel PA, Bliden KP, Logan DK, Kereiakes DJ, Lasseter KC, White A et al (2013) The influence of smoking status on the pharmacokinetics and pharmacodynamics of clopidogrel and prasugrel: the PARADOX study. J Am Coll Cardiol 62:505\u2013512","journal-title":"J Am Coll Cardiol"},{"key":"1207_CR24","doi-asserted-by":"crossref","first-page":"1511","DOI":"10.1016\/j.amjcard.2009.07.015","volume":"104","author":"N Bonello-Palot","year":"2009","unstructured":"Bonello-Palot N, Armero S, Paganelli F, Mancini J, De Labriolle A, Bonello C et al (2009) Relation of body mass index to high on-treatment platelet reactivity and of failed clopidogrel dose adjustment according to platelet reactivity monitoring in patients undergoing percutaneous coronary intervention. Am J Cardiol 104:1511\u20131515","journal-title":"Am J Cardiol"},{"key":"1207_CR25","doi-asserted-by":"crossref","first-page":"2430","DOI":"10.2337\/diabetes.54.8.2430","volume":"54","author":"DJ Angiolillo","year":"2005","unstructured":"Angiolillo DJ, Fernandez-Ortiz A, Bernardo E, Ram\u00edrez C, Sabat\u00e9 M, Jimenez-Quevedo P et al (2005) Platelet function profiles in patients with type 2 diabetes and coronary artery disease on combined aspirin and clopidogrel treatment. Diabetes 54:2430\u20132435","journal-title":"Diabetes"},{"key":"1207_CR26","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1161\/CIRCGENETICS.110.958561","volume":"3","author":"US Tantry","year":"2010","unstructured":"Tantry US, Bliden KP, Wei C, Storey RF, Armstrong M, Butler K et al (2010) First analysis of the relation between CYP2C19 genotype and pharmacodynamics in patients treated with ticagrelor versus clopidogrel: the ONSET\/OFFSET an RESPOND genotype studies. Circ Cardiovasc Genet 3:556\u2013566","journal-title":"Circ Cardiovasc Genet"},{"key":"1207_CR27","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1016\/S0140-6736(13)61170-8","volume":"382","author":"GW Stone","year":"2013","unstructured":"Stone GW, Witzenbichler B, Weisz G, Rinaldi MJ, Neumann FJ, Metzger DC et al (2013) Platelet reactivity and clinical outcomes after coronary artery implantation of drug-eluting stents (ADAPT-DES): a prospective multicenter registry study. Lancet 382:614\u2013623","journal-title":"Lancet"},{"key":"1207_CR28","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1067\/mhj.2003.109","volume":"145","author":"PA Gurbel","year":"2003","unstructured":"Gurbel PA, Cummings CC, Bell CR, Alford AB, Meister AF, Serebruany VL (2003) Onset and extent of platelet inhibition by clopidogrel loading in patients undergoing elective coronary stenting: the plavix reduction of new thrombus occurrence (PRONTO) trial. Am Heart J 145:239\u2013247","journal-title":"Am Heart J"},{"key":"1207_CR29","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.1001\/jama.2011.290","volume":"305","author":"MJ Price","year":"2011","unstructured":"Price MJ, Angiolillo DJ, Teirstein PS, Lillie E, Manoukian SV, Berger PB et al (2011) Standard- versus high-dose clopidogrel based on platelet function testing after percutaneous coronary intervention: the GRAVITAS randomized trial. JAMA 305:1097\u20131105","journal-title":"JAMA"},{"key":"1207_CR30","doi-asserted-by":"crossref","first-page":"2159","DOI":"10.1016\/j.jacc.2012.02.026","volume":"59","author":"D Trenk","year":"2012","unstructured":"Trenk D, Stone GW, Gawaz M, Kastrati A, Angiolillo DJ, M\u00fcller U et al (2012) A randomized trial of prasugrel versus clopidogrel in patients with high platelet reactivity on clopidogrel after elective percutaneous coronary intervention with implantation of drug-eluting stents: results of the TRIGGER-PCI (testing platelet reactivity in patients undergoing elective stent placement on clopidogrel to guide alternative therapy with prasugrel) study. J Am Coll Cardiol 59:2159\u20132164","journal-title":"J Am Coll Cardiol"},{"key":"1207_CR31","doi-asserted-by":"crossref","first-page":"2100","DOI":"10.1056\/NEJMoa1209979","volume":"367","author":"JP Collet","year":"2012","unstructured":"Collet JP, Cuisset T, Rang\u00e9 G, Cayla G, Elhadad S, Pouillot C et al (2012) Bedside monitoring to adjust antiplatelet therapy for coronary stenting. N Engl J Med 367:2100\u20132109","journal-title":"N Engl J Med"}],"container-title":["Journal of Thrombosis and Thrombolysis"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11239-015-1207-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11239-015-1207-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11239-015-1207-5","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,7]],"date-time":"2024-06-07T23:56:31Z","timestamp":1717804591000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11239-015-1207-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,3,24]]},"references-count":31,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2015,7]]}},"alternative-id":["1207"],"URL":"https:\/\/doi.org\/10.1007\/s11239-015-1207-5","relation":{},"ISSN":["0929-5305","1573-742X"],"issn-type":[{"value":"0929-5305","type":"print"},{"value":"1573-742X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,3,24]]}}}